1.17
Vivani Medical Inc stock is traded at $1.17, with a volume of 299.79K.
It is down -6.40% in the last 24 hours and down -8.59% over the past month.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
See More
Previous Close:
$1.25
Open:
$1.24
24h Volume:
299.79K
Relative Volume:
1.01
Market Cap:
$95.01M
Revenue:
-
Net Income/Loss:
$-25.65M
P/E Ratio:
-2.3878
EPS:
-0.49
Net Cash Flow:
$-24.59M
1W Performance:
-4.88%
1M Performance:
-8.59%
6M Performance:
-7.87%
1Y Performance:
+3.54%
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
415-506-8462
Address
1350 S. LOOP ROAD, ALAMEDA
Compare VANI vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VANI
Vivani Medical Inc
|
1.17 | 101.51M | 0 | -25.65M | -24.59M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Vivani Medical Inc Stock (VANI) Latest News
Vivani Medical Secures Funding and Clinical Momentum for Vision Restoration Technology - AD HOC NEWS
Earnings Report: Will Synaptics Incorporated benefit from sector rotationRate Cut & Entry and Exit Point Strategies - baoquankhu1.vn
Earnings Miss: Is Trex Company Inc stock forming a cup and handleJuly 2025 Setups & Community Verified Trade Signals - baoquankhu1.vn
Macro Review: How do insiders feel about HOLXTake Profit & Verified Technical Signals - baoquankhu1.vn
Breakouts Watch: What are OSI Systems Incs recent SEC filings showingPortfolio Profit Report & Fast Gaining Stock Reports - baoquankhu1.vn
Wednesday’s Insider Activity: Major Buys at Berkley, Sells at CoreWeave By Investing.com - Investing.com South Africa
Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026 - The Manila Times
Vivani Subsidiary Cortigent Presents Promising 6-Year Early - GlobeNewswire
Vivani Medical closes $4.5 million stock offering to fund research By Investing.com - Investing.com India
Vivani Medical (NASDAQ:VANI) Director Acquires 1,351,351 Shares - MarketBeat
Williams Gregg buys Vivani Medical (VANI) shares for $1.99m By Investing.com - Investing.com Nigeria
Williams Gregg buys Vivani Medical (VANI) shares for $1.99m - Investing.com
Vivani Medical prices common stock offering - MSN
Vivani Medical closes $4.5 million stock offering to fund research - Investing.com
Vivani Medical Announces Equity Offerings to Fund Pipeline - TipRanks
Vivani Medical, Inc. Announces Closing of Common Stock Offering - The Manila Times
Vivani Medical, Inc. Closes $4.5 Million Direct Offering and Private Placement to Support Clinical Development - Quiver Quantitative
Vivani Medical Signs Multiple Material Agreements - TradingView
Aclaris Therapeutics (NASDAQ:ACRS) versus Vivani Medical (NASDAQ:VANI) Head to Head Review - Defense World
Vivani Medical Prices $4.5M Offering for Growth Initiatives - Intellectia AI
Vivani Medical prices $4.5 million stock offering at $1.48 per share - Investing.com Australia
Vivani Medical prices $4.5 million stock offering at $1.48 per share By Investing.com - Investing.com South Africa
Vivani chair backs $4.5M raise for long-acting drug implants - Stock Titan
Vivani Medical announces pricing of common stock offering at $1.48 per share - marketscreener.com
Vivani Medical Announces Pricing Of Common Stock Offering At $1.48 Per Share - TradingView
Vivani Medical, Inc. Announces Pricing of Common Stock Offering - ChartMill
Vivani Medical, Inc. (NASDAQ:VANI) insiders have had a fantastic week as stock increased 17%, and they haven't stopped buying - simplywall.st
Insiders Rewarded With US$1.9m Addition To Investment As Vivani Medical Stock Hits US$110m - Yahoo Finance
Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026 - Sahm
Vivani Subsidiary Cortigent to Present Orion System’s - GlobeNewswire
Williams buys Vani shares worth $1.98 million By Investing.com - Investing.com Australia
Insider Buying: Vivani Medical (NASDAQ:VANI) Director Purchases 1,737,765 Shares of Stock - MarketBeat
Williams buys Vani shares worth $1.98 million - Investing.com
Valuation Update: Is SiTime Corporation impacted by rising ratesJuly 2025 Fed Impact & Consistent Growth Equity Picks - baoquankhu1.vn
Analysis Recap: Is Vivani Medical Inc a strong growth stockJuly 2025 Levels & Daily Momentum Trading Reports - baoquankhu1.vn
EBIT per share of Vivani Medical Inc. – FWB:U5P - TradingView — Track All Markets
Vivani Medical : 2026 Investor Presentation - MarketScreener
Will Vivani Medical Inc. stock split attract more investorsWeekly Gains Report & Safe Entry Point Identification - ulpravda.ru
Second Sight Medical Products, Inc.Common Stock (NQ: EYES - FinancialContent
Why Vivani Medical Inc. stock appeals to dividend seekers2026 world cup usa national team semifinals top scorers set piece tactics expert forecast expert opinion - Улправда
Vivani medical director Mendelsohn buys $24,600 in VANI stock By Investing.com - Investing.com South Africa
Vivani medical director Mendelsohn buys $24,600 in VANI stock - Investing.com
Vivani Medical Inc Stock (VANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):